SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • November 10th, 2015 • Zosano Pharma Corp • Pharmaceutical preparations • Delaware
THIS SCIENTIFIC ADVISOR AGREEMENT (this “Agreement”) is made and entered into as of December 31, 2015 (the “Effective Date”), by and among Zosano Pharma Corporation, a Delaware corporation having its principal place of business at 34790 Ardentech Court, Fremont, California 94555 (the “Parent”), ZP Opco, Inc., a Delaware corporation and wholly owned subsidiary of Parent (the “Company”), and PETER DADDONA, an individual residing at 35 Anderson Way, Menlo Park, California 94025 (the “Advisor”). The Parent, Company and Advisor may be referred to herein individually as a “Party” or collectively as the “Parties.”
Re: Amendment No. 4 to Employment AgreementEmployment Agreement • November 10th, 2015 • Zosano Pharma Corp • Pharmaceutical preparations • California
This letter agreement (this “Amendment No.4”) amends certain provisions of your employment letter agreement with ZP Opco, Inc., a Delaware corporation formerly named Zosano Pharma, Inc. (the “Company”), and Zosano Pharma Corporation, a Delaware corporation formerly named ZP Holdings, Inc. (“Parent”), dated May 11, 201 2 (the “Original Agreement”), as amended by the letter agreements dated January 6, 2014 (“Amendment No.1”), January 16, 2014 (“Amendment No. 2”) and May 29, 2015 (“Amendment No.3”) among you, the Company and Parent. The Original Agreement, as amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3, is referred to herein as the “Employment Agreement.”
